153 related articles for article (PubMed ID: 2453492)
1. A supertypic HLA class II determinant shared by DR1 and DRw9, and crossreactive with DR2, defined by human monoclonal antibody.
Kosinski S; Yang SY; Pistillo MP; Hämmerling U
Hum Immunol; 1988 Mar; 21(3):221-31. PubMed ID: 2453492
[TBL] [Abstract][Full Text] [Related]
2. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
Horibe K; Knowles RW; Dupont B
Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody that detects a polymorphic determinant common to HLA-DR1 and 2.
Kasahara M; Ogasawara K; Ikeda H; Okuyama T; Ishikawa N; Takenouchi T; Wakisaka A; Kikuchi Y; Aizawa M
Tissue Antigens; 1983 Feb; 21(2):105-13. PubMed ID: 6189259
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
[TBL] [Abstract][Full Text] [Related]
5. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
6. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody detecting an HLA-DQwl-related determinant.
Koning F; Raghoebar J; Schreuder GM; Schuurman R; Bruning H
Tissue Antigens; 1985 Aug; 26(2):100-9. PubMed ID: 2414859
[TBL] [Abstract][Full Text] [Related]
8. The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.
Crepaldi T; Richiardi P; Malavasi F; Carbonara AO; Igarashi M; Ferrone S
Tissue Antigens; 1985 Jul; 26(1):25-34. PubMed ID: 2412306
[TBL] [Abstract][Full Text] [Related]
9. A human monoclonal antibody to an HLA-DRw53 (MT3)-like epitope on class II antigens.
Kosinski S; Hämmerling U; Yang SY
Tissue Antigens; 1986 Sep; 28(3):150-62. PubMed ID: 2431513
[TBL] [Abstract][Full Text] [Related]
10. A division of HLA-DQw1 associated with DR1, DR1x-DQw1, DR2 short, DRw10, and DRw14. I. Definition by alloantiserum LY 1327.
Gebuhrer L; Betuel H; Lambert J; Freidel AC; Farre A
Hum Immunol; 1987 Mar; 18(3):235-45. PubMed ID: 2437088
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
Puri NK; de Kretser T; Brandon MR
Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
[TBL] [Abstract][Full Text] [Related]
12. A mouse monoclonal antibody against a polymorphic determinant in a defined subset of DR molecules.
Mazzilli MC; Tanigaki N; Cascino I; Costanzi Porrini S; Trabace S; Cappellacci S; Testa L; Gandini E
Hum Immunol; 1986 Jun; 16(2):148-56. PubMed ID: 2424872
[TBL] [Abstract][Full Text] [Related]
13. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
[TBL] [Abstract][Full Text] [Related]
14. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.
Aparicio P; Jaraquemada D; López de Castro JA
J Exp Med; 1987 Feb; 165(2):428-43. PubMed ID: 3102669
[TBL] [Abstract][Full Text] [Related]
15. A cytotoxic monoclonal antibody (HU-39) that detects DRw8 + DRw12.
Nakayama T; Ogasawara K; Ikeda H; Kunikane H; Kasahara M; Ishikawa N; Fukasawa Y; Hawkin S; Kojima H; Wakisaka A
Hum Immunol; 1987 Jun; 19(2):117-26. PubMed ID: 3497138
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal mouse anti-rat Ia antibody which cross reacts with a human HLA-DRw determinant.
McMaster WR; Winearls BC; Parham P
Tissue Antigens; 1979 Nov; 14(5):453-8. PubMed ID: 12731578
[TBL] [Abstract][Full Text] [Related]
17. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
[TBL] [Abstract][Full Text] [Related]
18. Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. II. Population analyses and blocking studies with monoclonal antibodies.
Rosen-Bronson S; Johnson AH; Hartzman RJ; Eckels DD
Immunogenetics; 1986; 24(5):286-97. PubMed ID: 3491043
[TBL] [Abstract][Full Text] [Related]
19. Epitope analysis with monoclonal antibodies directed against class II molecules subdivides HLA-DR2, DR3 and DR4: correlations with cellularly defined Dw specificities.
Johnson JP; Nordwig H; Wank R
Tissue Antigens; 1987 Jan; 29(1):26-33. PubMed ID: 2438806
[TBL] [Abstract][Full Text] [Related]
20. Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules.
Ballas M; Eiermann TH; Wölpl A; Goldmann SF
Tissue Antigens; 1990 Nov; 36(5):187-93. PubMed ID: 1710076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
